Your Article Summary
See Latest ArticlesCell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
Cell Therapeutics, 06/18/09
Cell Therapeutics, Inc. announced the preliminary results of its separate concurrent fixed price exchange offers for any and all of the approximately $118.9 million outstanding principal amount of five series of its convertible notes. The Exchange Offers expired at New York City time, on Tuesday, June 2009.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
A holiday message from AHA President and CEO Rich Umbdenstock
American Hospital Association News, 12/11/09
Nursing I.T. Award Deadline Dec. 2
HealthDataManagement, 12/10/09
Astellas Inducted into National Minority Transplant Hall of Fame
Astellas, 12/09/09